Drug application
KAFOCIN (CEPHALOGLYCIN)
Drugs@FDA NDA 050219 · LILLY
Key facts
| Drug name | KAFOCIN |
|---|---|
| Active ingredients | CEPHALOGLYCIN |
| Application type | NDA |
| Application number | 050219 |
| Company | LILLY |
| Dosage forms | CAPSULE, ORAL |
| Strength | 250MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Jun 12, 1970 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.